Clinical Trial Update: Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial investigating combined radiotherapy and radiofrequency ablation for hepatocellular carcinoma is in early/status-unknown stage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN